Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs

MJW McPate, RS. Duncan, JC Hancox, HJ Witchel

Research output: Contribution to journalArticle (Academic Journal)peer-review

70 Citations (Scopus)
Translated title of the contributionPharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs
Original languageEnglish
Pages (from-to)957 - 966
JournalBritish Journal of Pharmacology
Volume155
Publication statusPublished - 2008

Cite this